149 related articles for article (PubMed ID: 20473733)
41. Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial.
Ikeda M; Kudo M; Aikata H; Nagamatsu H; Ishii H; Yokosuka O; Torimura T; Morimoto M; Ikeda K; Kumada H; Sato T; Kawai I; Yamashita T; Horio H; Okusaka T;
J Gastroenterol; 2018 Feb; 53(2):281-290. PubMed ID: 28766016
[TBL] [Abstract][Full Text] [Related]
42. Comparative efficacy and safety of Chinese herbal injections combined with transcatheter hepatic arterial chemoembolization in treatment of liver cancer: a bayesian network Meta-analysis.
Zhang D; Wang K; Zheng J; Wu J; Duan X; Ni M; Liu S; Zhang B; Zhao Y
J Tradit Chin Med; 2020 Apr; 40(2):167-187. PubMed ID: 32242383
[TBL] [Abstract][Full Text] [Related]
43. 131I-Labeled-Metuximab Plus Transarterial Chemoembolization in Combination Therapy for Unresectable Hepatocellular Carcinoma: Results from a Multicenter Phase IV Clinical Study.
Ma J; Wang JH
Asian Pac J Cancer Prev; 2015; 16(17):7441-7. PubMed ID: 26625741
[TBL] [Abstract][Full Text] [Related]
44. Polyvinyl alcohol terminal chemoembolization for hepatocellular carcinoma with hepatic arteriovenous shunts: Safety, efficacy, and prognostic factors.
Liu QS; Mei QL; Li YH
Eur J Radiol; 2017 Apr; 89():277-283. PubMed ID: 27908612
[TBL] [Abstract][Full Text] [Related]
45. A traditional Chinese herbal medicine compound preparation versus interventional therapy after resection of small hepatocellular carcinoma: 22-year follow-up.
Sun Z; Liang ST; Zhai XF; Lang QB; Zhou QH; Yue XQ; He J; Xu J; Zhu Y; Ling CQ
J Tradit Chin Med; 2012 Jun; 32(2):156-63. PubMed ID: 22876437
[TBL] [Abstract][Full Text] [Related]
46. [Analysis on the prognostic factors in patients with large hepatocarcinoma treated by shentao ruangan pill and hydroxycamptothecine].
Lin LZ; Zhou DH; Liu K; Wang FJ; Lan SQ; Ye XW
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jan; 25(1):8-11. PubMed ID: 15719740
[TBL] [Abstract][Full Text] [Related]
47. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
Wu F; Wang ZB; Chen WZ; Zou JZ; Bai J; Zhu H; Li KQ; Jin CB; Xie FL; Su HB
Radiology; 2005 May; 235(2):659-67. PubMed ID: 15858105
[TBL] [Abstract][Full Text] [Related]
48. Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B-C hepatocellular carcinoma.
Chiang CL; Chan MKH; Yeung CSY; Ho CHM; Lee FAS; Lee VWY; Wong FCS; Blanck O
Strahlenther Onkol; 2019 Mar; 195(3):254-264. PubMed ID: 30413833
[TBL] [Abstract][Full Text] [Related]
49. Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis.
Cho WC; Chen HY
Expert Opin Investig Drugs; 2009 May; 18(5):617-35. PubMed ID: 19388879
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic benefits of combined sorafenib for intermediate hepatocellular carcinoma unresponsive to transarterial chemoembolization in a Chinese population.
Lee SW; Tung CF; Peng YC; Lien HC; Chang CS
J Dig Dis; 2020 Aug; 21(8):462-467. PubMed ID: 32472590
[TBL] [Abstract][Full Text] [Related]
51. Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial.
Zhai XF; Chen Z; Li B; Shen F; Fan J; Zhou WP; Yang YK; Xu J; Qin X; Li LQ; Ling CQ
J Integr Med; 2013 Mar; 11(2):90-100. PubMed ID: 23506690
[TBL] [Abstract][Full Text] [Related]
52. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
[TBL] [Abstract][Full Text] [Related]
53. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
[TBL] [Abstract][Full Text] [Related]
55. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience.
Stefanini GF; Amorati P; Biselli M; Mucci F; Celi A; Arienti V; Roversi R; Rossi C; Re G; Gasbarrini G
Cancer; 1995 May; 75(10):2427-34. PubMed ID: 7736385
[TBL] [Abstract][Full Text] [Related]
57. Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial.
Qu J; Yu Z; Li Q; Chen Y; Xiang D; Tan L; Lei C; Bai W; Li H; Shang Q; Chen L; Hu X; Lu W; Li Z; Chen D; Wang X; Zhang C; Xiao G; Qi X; Chen J; Zhou L; Chen G; Li Y; Zeng Z; Rong G; Dong Z; Chen Y; Lou M; Wang C; Lu Y; Zhang C; Yang Y
Trials; 2014 Nov; 15():438. PubMed ID: 25381721
[TBL] [Abstract][Full Text] [Related]
58. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
[TBL] [Abstract][Full Text] [Related]
59. Chinese herbal medicine, Jianpi Ligan decoction, improves prognosis of unresectable hepatocellular carcinoma after transarterial chemoembolization: a retrospective study.
Tang CW; Zhu M; Feng WM; Bao Y; Zheng YY
Drug Des Devel Ther; 2016; 10():2461-6. PubMed ID: 27536066
[TBL] [Abstract][Full Text] [Related]
60. Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
Brown KT; Do RK; Gonen M; Covey AM; Getrajdman GI; Sofocleous CT; Jarnagin WR; D'Angelica MI; Allen PJ; Erinjeri JP; Brody LA; O'Neill GP; Johnson KN; Garcia AR; Beattie C; Zhao B; Solomon SB; Schwartz LH; DeMatteo R; Abou-Alfa GK
J Clin Oncol; 2016 Jun; 34(17):2046-53. PubMed ID: 26834067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
